See the presentation that convinced investors like CapitalG to back a new kind of kidney care startup

Hello,

Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:

• We got the pitch deck that kidney-care startup Strive Health used to raise $140 million in its Series B;
• How DNA-testing companies are shaping the next chapter of the genetics industry;
• Moderna has started its vaccine trial in kids between 6 months and 12 years.

If you're new to this newsletter, sign up here. Comments, tips, recipes? Email me at [email protected] or tweet @lydiaramsey125. Now, let's get to it…

---

Alphabet's VC arm just sank $140 million into a startup that wants to unseat dialysis giants like DaVita. We got the pitch deck that convinced CapitalG to back Strive Health.

• Strive Health raised $140 million in Series B funding on Tuesday. Alphabet's CapitalG led the round.
• The startup works with insurers and health systems on a new way to care for people with mid- and late-stage kidney disease.

See the presentation that won over investors >>

---

How 5 top DNA-testing companies like 23andMe and Color are shaping the next chapter of the genetics industry

• 23andMe in February said it's going public in a deal that values the company at $3.5 billion.
• Despite 23andMe's success, the consumer genomics market has largely bottomed out, an analyst said.
• Others hoping to cash in on genetic health assessments have pivoted or shuttered efforts altogether.

Find out how top players are navigating the industry's future>>

---

Moderna begins testing its COVID-19 vaccine in babies and young children

• Moderna has begun testing its COVID-19 vaccine in children between 6 months and 12 years old.
• It plans to enroll 6,750 participants in the US and Canada in the trial.
• Getting children vaccinated is crucial to reaching herd immunity, according to Dr. Anthony Fauci.

Read on about the trial just getting underway>>

---

More stories we're reading today:

• The growing list of countries suspending use of the AstraZeneca vaccine may be doing much more harm than good, experts say (Insider)
• Grand Rounds is merging with Doctor on Demand in the latest digital health consolidation (CNBC)
• 65 of 100 of the largest hospitals in the US aren't complying with the new price transparency rule (Modern Healthcare)
• Weddings could be safe this spring and summer, experts say - here's how to go about it (Insider)

---

- Lydia